Cannabis became fully legal in Canada today (Oct. 17), and that's just one big reason to know the top weed stocks to watch in October 2018.
Up to eight U.S. states will vote on ballot measures related to marijuana this fall. By 2021, legal marijuana could become a powerhouse industry, worth a whopping $24.5 billion in the U.S. alone.
And these are two of the best cannabis stocks to watch this year...
Walmart Inc. (NYSE: WMT) might be one of the biggest retailers in North America, but it's never lost sight of its conservative Arkansas roots.
That's why many are surprised to learn that Walmart could begin selling cannabis products in its more than 400 Canadian stores.
But we're not surprised.
Here's everything you need to know about Walmart's potential cannabis sales...
Walmart has rarely wavered from founder Sam Walton's gospel of Christian free enterprise or his conservatism.
So it should come as no surprise that, over the years, the world's largest retailer has taken stands against medical marijuana laws, sometimes refusing to cover employees' legal cannabis prescriptions.
So the most recent news coming out of Bentonville, Ark., was a bit shocking.
Earlier this week, Walmart's Canadian division said it's exploring the possibility of selling cannabis-infused products its stores.
While various global beverage and tobacco giants have been showing interest in the legal cannabis market, Walmart is the first big retailer do so – and probably the most surprising choice possible.
What's next? Cannabis grow kits at Hobby Lobby? Marijuana-infused nuggets at Chick-fil-A?
Even more jaw-dropping is that this, technically, isn't Walmart's first foray into pot...
There are plenty of tempting, speculative plays in the market right now with everything that's going on, but today our Quantitative Speculative is targeting the "big boys" of pot stocks with his speculative play.
Find out what happens when "Best in Breed" meets the best in weed...
by Greg Miller
Summer 2018 was a season of surprises – mostly great ones – for cannabis investing.
Not long ago, few foresaw Corona's parent corporation Constellation Brands investing $3.8 million in what was already the world's biggest cannabis producer in its second deal together in less than a year…
Or Coca-Cola Co. starting negotiations with a cannabis company about a potential CBD-based beverage…
Or a British pharmaceutical developer getting the first U.S. Food & Drug Association approval for a cannabis-based medicine.
Yet every one of those events happened… in short order.
With each time, cannabis stocks soared accordingly, especially for the companies directly involved.
Big news means major moves when it comes to cannabis investing.
But what I see as the biggest, most shocking developments of late haven't been happening in a board room. They've been happening in the shadows of the Capitol in Washington, D.C.
The U.S. cannabis policy thaw is already underway, and the ongoing developments associated with it are going to be game changers for investors who don't wait for too long on the sidelines.
These are first-time events that herald a brand-new era of cannabis profits for shareholders.
We're talking about real movement in the slow and steady end of the longtime federal prohibition of marijuana.
Here are the three things I'm watching closest...
The legal cannabis industry could explode from $10 billion this year to $57 billion over the coming decade.
That 470% growth potential has investors pouring money into the industry, and one of the most popular ways to do it is through cannabis ETFs.
But that's a costly mistake...
Finding the top pot stocks to watch can be difficult.
That's why we wanted to help.
Here are two of the top pot stocks to watch...
Last month, the Canadian Federal government passed laws to legalize recreational marijuana nationally, opening the floodgates to billions of dollars in marijuana investment.
This is just the latest development in a wave of legalization efforts over the last several years that are breaking through decades of stringent cannabis legalization – and creating profits for marijuana stocks in the process.
June saw some incredibly exciting developments in the marijuana industry.
On June 5th, Canada's Senate passed legislation that made recreational marijuana legalization imminent for the Canadian commonwealth.
Meanwhile, the U.S. Food and Drug Administration granted approval for Epidiolex – the nation's first cannabis-based drug that will be used to treat rare forms of epilepsy.
Here we are.
It's taken years of trials and experiments, but this week, the U.S. Food and Drug Administration (FDA) made history by approving the first cannabis plant-derived drug pharmaceutical.
And that makes the drug's developer and owner, as well as our long-time Roadmap to Marijuana Millions cannabis biotech play – the United Kingdom's GW Pharmaceuticals Plc. – a pioneer in marijuana-based medical treatments.
What a week to be early investors in weed…
